Ze'ev Ronai
zronai.bsky.social
Ze'ev Ronai
@zronai.bsky.social
Professor, Depts Surgery & Biomedical Sciences, Director Translational Research Institute, Cedars Sinai, LA, USA
Reposted by Ze'ev Ronai
The SMR 2025 Annual Congress (Amsterdam Oct 25-28) covers basic, preclinical & translational melanoma research of international top investigators. It is a very enjoyable conference with top faculty and now improved with ample opportunity for young investigators to network. Join us! smrcongress.org
Society Melanoma Research Congress
smrcongress.org
July 4, 2025 at 12:23 PM
Can one attenuate the eIF4F complex without toxicity? Read how we accomplished this complex task, enabling to overcome resistance to therapy and inhibit melanoma growth. work performed by Yongmei Feng (SBP discovery) in collaboration with exprests in McGill Univ. and Vancouver Prostate Centre
Targeting eIF4G1-dependent translation in melanoma
Elevated expression of components of eIF4F translation initiation complex has been documented in cancer, resulting in enhanced translation of mRNAs encoding pro-tumorigenic factors, including oncogeni...
www.biorxiv.org
November 28, 2024 at 10:01 PM
Analysis of macrophages in melanoma metastasis of aged mice identified elevated expression of TREM2 (also seen in human melanoma). Inhibition of TREM2 blocked metastatic spread in preclinical mouse studies. Marzia Scortegagna led the study at SBP Discovery. Read more at:
Age-associated modulation of TREM1/2- expressing macrophages promotes melanoma progression and metastasis
Aging is a known risk factor for melanoma, yet mechanisms underlying melanoma progression and metastasis in older populations remain largely unexplored. Among the current knowledge gaps is how aging a...
www.biorxiv.org
November 24, 2024 at 2:07 AM